Back to discover
Drug

Vitamin B 6

In clinical development
Emerging researchLate-stage development
Also known as Animi-3, Animi-3 with Vitamin D, Beelith, Bonjesta+50 more

Animi-3, Animi-3 with Vitamin D, Beelith, Bonjesta, Concept OB, Dialyvite 800, Dialyvite 800 + Iron, Dialyvite 800 with Iron, Dialyvite 800 with Zinc, Diclegis, Doxylamine-Pyridoxine, Eldertonic, Ellis Tonic, Encora AM Tablet, Encora PM Tablet, Ferrocite Plus, Folbecal, Foleve, Folgard OS, FoliNatal Plus B, Folnate, Folpace Rx, Hemocyte Plus, Infuvite, Infuvite Pediatric, Irospan Tablet, Lactocal, Melatonex, Multi-Delyn, Natafort, Natelle, Nephrocaps, Nephrocaps QT, NicAzel, PYRIDOXINE, Piridoxina, PreNexa, Premesis Rx, Pyridoxinum, Pyridoxol, Rena-Vite, Tandem OB, Tandem Plus, Vita-Respa, Vitabee with C, Vitafol-One, Vitamin B6 (Pyridoxine), pyridoxine (vit B6), Vitamin B6, VitaminB6, 2-methyl-3-hydroxy-4,5-dihydroxymethylpyridine, 3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine, 5-hydroxy-6-methyl-3,4-pyridinedimethanol, Pyridoxine Hydrochloride.

1
Research papers
2
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Short Course Low Dose Oral Colchicine After ST Elevation Myocardial Infarction(STEMI)

Clinical trial2023-12-29Primary completion · ClinicalTrials.gov

Homocysteine lowering with folic acid and B vitamins in vascular disease.

Research2006-03-12The New England journal of medicine

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Vitamin B 6
Aliases & brands
Animi-3Animi-3 with Vitamin DBeelithBonjestaConcept OBDialyvite 800Dialyvite 800 + IronDialyvite 800 with IronDialyvite 800 with ZincDiclegisDoxylamine-PyridoxineEldertonicEllis TonicEncora AM TabletEncora PM TabletFerrocite PlusFolbecalFoleveFolgard OSFoliNatal Plus BFolnateFolpace RxHemocyte PlusInfuviteInfuvite PediatricIrospan TabletLactocalMelatonexMulti-DelynNatafortNatelleNephrocapsNephrocaps QTNicAzelPYRIDOXINEPiridoxinaPreNexaPremesis RxPyridoxinumPyridoxolRena-ViteTandem OBTandem PlusVita-RespaVitabee with CVitafol-OneVitamin B6 (Pyridoxine)pyridoxine (vit B6)Vitamin B6VitaminB62-methyl-3-hydroxy-4,5-dihydroxymethylpyridine3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine5-hydroxy-6-methyl-3,4-pyridinedimethanolPyridoxine Hydrochloride
RxNorm CUI
684879
ChEMBL ID
CHEMBL1364
ATC codes
A11HA02
UNII
KV2JZ1BI6Z

Clinical trials

46 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
46
registered trials across all phases
LATEST COMPLETION 2022
2
Active studies
28
Late-stage (III+)
30
Completed
14
Discontinued
PHASE DISTRIBUTIONn = 46
Early Phase 11Phase 13Phase 1 / 24Phase 210Phase 2 / 31Phase 312Phase 45Phase N / A10

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Most influential

Homocysteine lowering with folic acid and B vitamins in vascular disease.

The New England journal of medicine · 2006 · 1,113 cites
Recent papers

Homocysteine lowering with folic acid and B vitamins in vascular disease.

The New England journal of medicine · 2006 · 1,113 cites
Journals, researchers & institutions
Top journals
  • The New England journal of medicine1
Leading researchers
  • Arnold MJ1
  • Fodor G1
  • Genest J Jr1
  • Held C1
  • Lonn E1
  • McQueen MJ1
  • Micks M1
  • Pogue J1
Leading institutions
free-text, unnormalised
  • Population Health Research Institute1

Related drugs

1 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across 6 of the same disease areas as Vitamin B 6 in the shared literature.

6 shared diseases1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials